DAFNA Capital trims iShares Biotechnology ETF within broader biotech portfolio, according to recent SEC filing
According to a February 17, 2026 SEC filing, DAFNA Capital Management LLC reduced its stake in iShares Biotech ETF (NASDAQ:IBB) for 34,405 shares during the fourth quarter of 2025. The value of the fund’s quarter-end IBB position decreased by $3.31 million, a figure that took into account both share sales and price movement. Following the…